News

Vaiomer will be attending «Journées Polepharma de Microbiomique, 4ème édition»
Vaiomer will be taking part in the 4th edition of the « Journées Polepharma De Microbiomique » on November 22 & 23 in Rouen, FRANCE. More

Vaiomer will be attending «Journées Polepharma de Microbiomique, 4ème édition»

> Vaiomer will be taking part in the 4th edition of the « Journées Polepharma De Microbiomique » on November 22 & 23 in Rouen, FRANCE.
> Do not miss the amazing “Microbiota and Cancer” session introduced by our CSO, Benjamin LELOUVIER, on Thursday 23 at 14:00.

Vaiomer is taking part to « 7èmes JOURNEES SCIENTIFIQUES FRANCOPHONES du CALM»
>Vaiomer is happy to announce its participation to "7èmes JOURNEES SCIENTIFIQUES FRANCOPHONES du Club Alzheimer de Montpellier’’ on November 14&15".

Vaiomer is taking part to « 7èmes JOURNEES SCIENTIFIQUES FRANCOPHONES du CALM»

>We are excited to exchange and share new ideas with scientists and academics in the field of microbiota and Alzheimer’s research.
>Do not miss our talk presented by Benjamin LELOUVIER in the Microbiota session, on Wednesday, November 15.

Mouse models with human microbiome
Vaiomer and Physiogenex are proud to announce the launch of the TRANSBIOTIC project, to develop and validate mouse models with human microbiomes for evaluating therapies targeting metabolic and inflammatory diseases. Thanks La Région Occitanie-Pyrénées-Méditerranée for its support !

Mouse models with human microbiome

Physiogenex, a leading preclinical contract research organization specialized in metabolic diseases and complications, and Vaiomer, a pioneer company in the field of microbiota, launch the TRANSBIOTIC project: a new research project to transplant mice with human fecal microbiome isolated from patients suffering various metabolic and inflammatory diseases.

Vaiomer is honored to sponsor the « Journées Polepharma De Microbiomique, 3ème édition »
Vaiomer will attend the JPM22 meeting on the last advances in microbiota applications and translational research.

Vaiomer is honored to sponsor the « Journées Polepharma De Microbiomique, 3ème édition »

> Vaiomer will be taking part in the 3rd edition of the « Journées Polepharma De Microbiomique » on December 14th & 15th in Rouen, FRANCE.
> Join us on our booth #11 to learn more about microbiomes beyond the gut.
> Do not miss our talk on exploring the microbiomes from gut and beyond, Thursday 15th at 14:35.

Vaiomer is participating in the next Neurex meeting on advanced concepts in neuroimmunology
Vaiomer is taking part in the next Neurex meeting on advanced concepts in neuroimmunology

Vaiomer is participating in the next Neurex meeting on advanced concepts in neuroimmunology

> Vaiomer is taking part in the meeting “Advanced Concepts In Neuroimmunology: From Environmental Stressors To Neurological Disorders” on November 24 in Strasbourg, FRANCE.
> Do not miss our talk on “Tissue microbiota analysis for pathogen identification and skin microbiome alteration assessment after tick bite” at 14:45.

Vaiomer is honored to sponsor the Microbiome R&D and Business Collaboration Forum: Europe 2022
Vaiomer is happy to announce that we will be attending the Microbiome R&D and Business Collaboration Forum: Europe 2022

Vaiomer is honored to sponsor the Microbiome R&D and Business Collaboration Forum: Europe 2022

> Meet Vaiomer at the Microbiome R&D and Business Collaboration Forum on May 24 & 25, in The Hague, THE NETHERLANDS
> Come visit our booth and do not miss our talk “Bacterial translocation: a new perspective on the microbiota-gut-brain axis?”
> Do not miss our talk on how microbiomes contribute to tumor microenvironment, progression and treatment responsiveness.

Vaiomer is taking part to the next Eurobiomed cluster thematic meeting on Oncology
Vaiomer will present at the next Eurobiomed cluster thematic meeting on May 12 about Oncology

Vaiomer is taking part to the next Eurobiomed cluster thematic meeting on Oncology

> Vaiomer will be participating to Oncology: Horizon 2030 Technologies and models to address tumor heterogeneity for better personalized medicine, on May 12 in Toulouse, FRANCE.
> Do not miss our talk on how microbiomes contribute to tumor microenvironment, progression and treatment responsiveness.